Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Disclosing the diagnosis of multiple sclerosis: The Profile Project.
Th17 Cells: Biology, Pathogenesis of Autoimmune and Inflammatory Diseases, and Therapeutic Strategies.
Natalizumab in relapsing-remitting multiple sclerosis.
Back on the scent: the olfactory system in CNS demyelinating diseases.
Causes of Death among Commercially Insured Multiple Sclerosis Patients in the United States.
CD44 is required for the migration of transplanted oligodendrocyte progenitor cells to focal inflammatory demyelinating lesions in the spinal cord.
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment.
Pathophysiology of the brain extracellular matrix: a new target for remyelination.
Re-engineering of pathogenic aquaporin 4-specific antibodies as molecular decoys to treat neuromyelitis optica.
Clinical analysis of the etiology of optic neuritis in patients at different ages in china.
FDA Approves First Drug for Lou Gehrig's Disease
Alemtuzumab: A new therapy for active relapsing-remitting multiple sclerosis.
Compositional Changes of B and T Cell Subtypes during Fingolimod Treatment in Multiple Sclerosis Patients: A 12-Month Follow-Up Study.
Graves' disease after treatment with Alemtuzumab for multiple sclerosis.
Efficacy and safety of alemtuzumab in patients with relapsing-remitting multiple sclerosis who relapsed on prior therapy: Four-year follow-up of the Care-MS II study.
Personalized Medicine in Neurodegenerative Diseases: How Far Away?
CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis.
Impact of Depression, Fatigue and Disability on Quality of Life in Chinese Patients with Multiple Sclerosis.
Comprehensive Immunophenotyping of Cerebrospinal Fluid Cells in Patients with Neuroimmunological Diseases.
Vitamin D-binding protein and vitamin D status of black Americans and white Americans.
Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK.
Fine-tuning the central nervous system: microglial modelling of cells and synapses.
Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis.
Simvastatin: a review.
Elevation of Ser9 phosphorylation of GSK3β is required for HERV-W env-mediated BDNF signaling in human U251 cells.

Pages